New York Giants are partnering up with Quest Diagnostics to optimize their player training with new sports science technology. Through Quest’s baseline athletic performance testing service “Blueprint for Athletes,” players hope to be better trained for the NFL season.
The “Blueprint for Athletes” service provides player’s baseline screening in their annual physicals. Giants’ players have been given the opportunity to volunteer to work with Quest in the research and application of the service with ongoing monitoring and feedback providing. The medical and scientific teams hope to improve their product development with the players’ reviews.
Get The Latest NFL Tech News In Your Inbox!
With this new partnership, all Giants players began using the results from “Blueprint for Athletes” baseline analysis during the summer as part of their training (the Giants just recently announced in this partnership in late December). Test results provide individualized guidance for nutrition, thermoregulation, recovery and other aspects of training.
The New York Giants hope this new service will provide athletes with better insights into their health to help improve their performance and prevent injury.
“The insights we are learning through our partnership with Quest Diagnostics and our testing with Blueprint for Athletes have allowed us to pinpoint specific health markers that affect player performance so that we can focus on improvements,” said Ronnie Barnes, Senior Vice President of Medical Services, New York Football Giants. “Our athletic training staff, in conjunction with our strength and conditioning staff, is literally tracking measureable progress as we make modifications in diet, hydration, fueling and nutrition, oxygen transport and other factors during our training. That’s helping our team train not just harder, but smarter. Blueprint for Athletes has been a primary catalyst to improving our emphasis on player health and performance.”
This marks the third year of the partnership between the New York Giants and Quest Diagnostics, which seems to be a successful collaboration in the world of sports science. Giants’ linebacker Mark Herzlich is one of the players who began to use Blueprint for Athletes in beta form. While playing football at Boston College, Herzlich learned he had a rare form of bone cancer. He never thought he would be able to play football again but believes insights from “Blueprint for Athletes” were a major contributing point to his overall wellness and recovery.
“This partnership will allow us to help athletes everywhere improve their health and performance and is yet another example of how we are delivering on our vision to empower better health through diagnostic insights,” said Quest Diagnostics CEO Steve Rusckowski.